The New York Stock Exchange helped ring in this year’s Fierce 15 by honoring the winners on the trading floor Monday morning.

Consumer health brands face increasing pressure to demonstrate real-world impact, stand out in a crowded market, and adapt quickly to evolving consumer expectations. Traditional evidence-gathering ...

Precision medicine is reshaping the landscape of clinical development, offering more advanced strategies to align therapies with individual biological variability. Recent research shows that drug ...

Across the biotech industry, the demand for accelerated time to clinic, operational precision, and robust scalability has never been more critical. Developers face the complexity of solving a growing ...

As the life sciences industry contends with tighter economic conditions and increasing investor scrutiny, integrated innovation partners (IIPs) are emerging as a more effective model than traditional ...

You will receive an email confirmation momentarily. Please reach out to [email protected] with any questions. Use the below links to add this event to your calendar and be sure to check out other ...

Researchers are exploring the effectiveness of combining antibody drug conjugates and immune checkpoint inhibitors in non-small cell lung cancer. Precision medicine has improved the prognosis for ...

The resilience in Biopharma is facing a downturn. The 2023 Global Biopharma Resilience Index from Cytiva offers insights into the industry's current state, spotlighting both strong points and ...

A new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause sepsis and pneumonia without harming healthy gut microbes, research in mice shows. If further ...

With an increase in the number of clinical trials for gene-based therapies, there is an increase in genetic screening to identify patients for trials, stratify patients and ensure the safety of ...

Discover the patterns that emerge from real-world CDx development and post-approval projects. Struggling to achieve the widespread adoption of your precision medicine therapy? The missing piece might ...

The unprecedented changes in regulatory compliance, technological advancements, product cycle times, need for market access and international expansion have forced medical device companies to take a ...